Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | -.--% | +20.00% | -.--% |
Business Summary
Sales per Business
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Psychoactive Compounds, Development of Natural Health Care Products, and Mental Health Treatments
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
CAD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tim Moore
CEO | Chief Executive Officer | 66 | 06/20/06 |
Jenna Pozar
COO | Chief Operating Officer | - | 01/21/01 |
Director/Board Member | - | 04/20/04 | |
Ivan Casselman
BRD | Director/Board Member | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Moore
CEO | Chief Executive Officer | 66 | 06/20/06 |
Ivan Casselman
BRD | Director/Board Member | - | - |
Director/Board Member | - | 04/20/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 28,646,020 | 27,642,020 ( 96.50 %) | 0 | 96.50 % |
Company contact information
HAVN Life Sciences, Inc.
130 Brew Street Suite 605
V3H 0E3, Port Moody
+604 370 9520
http://www.havnlife.comSector
1st Jan change | Capi. | |
---|---|---|
-.--% | 625K | |
+26.28% | 42.68B | |
-3.99% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+6.36% | 24.94B | |
-21.47% | 18.96B | |
+27.58% | 12.3B | |
-2.75% | 11.95B | |
-2.02% | 11.55B |
- Stock Market
- Equities
- HAVN Stock
- Company HAVN Life Sciences Inc.